These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2408675)
21. Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma. Cheung MC; Wang DB; Lum KD; Albers JJ Biochim Biophys Acta; 1988 Sep; 962(2):258-64. PubMed ID: 3139041 [TBL] [Abstract][Full Text] [Related]
22. Japanese adult siblings with Tangier disease and statistical analysis of reported cases. Tarao K; Iwamura K; Fujii K; Miyake H Tokai J Exp Clin Med; 1984 Dec; 9(5-6):379-87. PubMed ID: 6443624 [TBL] [Abstract][Full Text] [Related]
23. A method to screen apolipoprotein polymorphisms in whole plasma: description of apolipoprotein A-IV variants in dyslipidemias and a reassessment of apolipoprotein A-I in Tangier disease. Bisgaier CL; Lee ES; Glickman RM Biochim Biophys Acta; 1987 Apr; 918(3):242-9. PubMed ID: 3105587 [TBL] [Abstract][Full Text] [Related]
24. Tangier disease with normal serum cholesterol. Frith RW; Hannan SF; Simcock JP; Scott PJ Aust N Z J Med; 1982 Oct; 12(5):515-9. PubMed ID: 6960872 [TBL] [Abstract][Full Text] [Related]
25. Urinary proteins in a patient with Tangier disease. Pritchard PH; Bergseth M; McLeod R; Hayden MR; Frohlich J Clin Biochem; 1985 Apr; 18(2):98-101. PubMed ID: 3926343 [TBL] [Abstract][Full Text] [Related]
29. Modified lipid-protein interactions in Tangier beta lipoprotein (LDL2) demonstrated by fluorescence quenching. Dumon MF; Dang QQ; Salvayre R; Clerc M; Douste-Blazy L Chem Phys Lipids; 1988 Dec; 49(3):153-60. PubMed ID: 3240561 [TBL] [Abstract][Full Text] [Related]
30. Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide. Brewer HB; Fairwell T; Meng M; Kay L; Ronan R Biochem Biophys Res Commun; 1983 Jun; 113(3):934-40. PubMed ID: 6409109 [TBL] [Abstract][Full Text] [Related]
31. The metabolic defect in Tangier Disease. Herbert PN N Engl J Med; 1979 Feb; 300(8):432-3. PubMed ID: 215911 [No Abstract] [Full Text] [Related]
32. [High density lipoproteins of the blood plasma and dysalphalipoproteinemia (a review)]. Polikarpova LI Vopr Med Khim; 1981; 27(5):579-90. PubMed ID: 7032061 [No Abstract] [Full Text] [Related]
33. Genetic high density lipoprotein deficiency states and atherosclerosis. Schaefer EJ; McNamara JR; Mitri CJ; Ordovas JM Adv Exp Med Biol; 1986; 201():1-15. PubMed ID: 3099550 [No Abstract] [Full Text] [Related]
34. Biochemical studies in a patient with a Tangier syndrome. Yao JK; Herbert PN; Fredrickson DS; Ellefson RD; Heinen RJ; Forte T; Dyck PJ J Neuropathol Exp Neurol; 1978; 37(2):138-54. PubMed ID: 632844 [TBL] [Abstract][Full Text] [Related]
35. Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease. Rees A; Stocks J; Schoulders C; Carlson LA; Baralle FE; Galton DJ Acta Med Scand; 1984; 215(3):235-7. PubMed ID: 6428166 [TBL] [Abstract][Full Text] [Related]
37. [Alphalipoproteinemia: evaluation of the utility of its determination]. Quintão EC Arq Bras Cardiol; 1980 Apr; 34(4):263-5. PubMed ID: 7436783 [No Abstract] [Full Text] [Related]
38. High-density lipoproteins and the risk of atherosclerosis. Lees RS; Lees AM N Engl J Med; 1982 Jun; 306(25):1546-8. PubMed ID: 7078610 [No Abstract] [Full Text] [Related]
39. The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease. Assmann G; Schmitz G; Heckers H Scand J Clin Lab Invest Suppl; 1978; 150():98-102. PubMed ID: 218282 [TBL] [Abstract][Full Text] [Related]
40. Lipid binding properties of the Tangier apolipoprotein A-I and its isoproteins. Rosseneu M; Assmann G; Taveirne MJ; Schmitz G J Lipid Res; 1984 Feb; 25(2):111-20. PubMed ID: 6423754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]